home / stock / rwlk / rwlk news


RWLK News and Press, ReWalk Robotics Ltd. From 02/22/21

Stock Information

Company Name: ReWalk Robotics Ltd.
Stock Symbol: RWLK
Market: NASDAQ

Menu

RWLK RWLK Quote RWLK Short RWLK News RWLK Articles RWLK Message Board
Get RWLK Alerts

News, Short Squeeze, Breakout and More Instantly...

RWLK - Celsion, Citius Pharmaceuticals leads healthcare gainers; Otonomy, Brainstorm Cell Therapeutics among major losers

Gainers: Celsion (CLSN) +54%, SunLink Health Systems (SSY) +27%, Citius Pharmaceuticals (CTXR) +26%, Can-Fite BioPharma (CANF) +19%, Aesthetic Medical International Holdings Group (AIH) +18%.Losers: Otonomy (OTIC) -43%, Brainstorm Cell Th...

RWLK - OTIC, VTRS among premarket losers

Otonomy (OTIC) -51% after Otividex fails late-stage Ménière’s disease study.Ebix (EBIX) -32% as auditor resigns after flagging material weakness.Energous (WATT) -20%.MoneyGram International (MGI) -17% on Q4 earnings.Petroleo Brasileiro S.A. - Petrobra...

RWLK - ReWalk Robotics Announces $40.0 Million Private Placement Priced At-the-Market

MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, Feb. 19, 2021 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that it has entered into securities purchase agreements with certain institutional and other ...

RWLK - ReWalk Robotics Ltd. (RWLK) CEO Larry Jasinski on Q4 2020 Results - Earnings Call Transcript

ReWalk Robotics Ltd. (RWLK) Q4 2020 Earnings Conference Call February 18, 2021 08:30 AM ET Company Participants Ori Gon - CFO Larry Jasinski - CEO Conference Call Participants Swayampakula Ramakanth - H.C. Wainwright Presentation Operator Ladies and gentlemen, thank you for standing by, and w...

RWLK - Immunome, Avinger leads healthcare gainers; MEDNAX, ReWalk Robotics among major losers

Gainers: Immunome (IMNM) +93%, Avinger (AVGR) +33%, Titan Pharmaceuticals (TTNP) +17%, GBS (GBS) +15%, VistaGen Therapeutics (VTGN) +15%.Losers: MEDNAX (MD) -23%, ReWalk Robotics (RWLK) -21%, Shineco (TYHT) -19%,&...

RWLK - ReWalK EPS in-line, misses on revenue

ReWalK (RWLK): Q4 GAAP EPS of -$0.14 in-line.Revenue of $1.2M (+1.7% Y/Y) misses by $0.3M.Press Release For further details see: ReWalK EPS in-line, misses on revenue

RWLK - ReWalk Robotics Reports Fourth Quarter and Year End 2020 Financial Results

— Annual revenue of $4.4 million in 2020 and $1.2 million for the fourth quarter of 2020 — — Continued CMS progress made with issuance of HCPCS Level II Code for ReWalk Exoskeleton enabling an upcoming application for coverage — — Debt repayment ...

RWLK - Diffusion Pharmaceuticals, Strongbridge Biopharma leads healthcare gainers; bluebird bio, Cortexyme among major losers

Gainers: Diffusion Pharmaceuticals (DFFN) +36%, Strongbridge Biopharma (SBBP) +25%, KemPharm (KMPH) +20%, Senseonics Holdings (SENS) +17%, ReWalk Robotics (RWLK) +14%.Losers: bluebird bio (BLUE) -32%, Cortexyme (CRTX) -30%, Inhi...

RWLK - ReWalk Robotics to Report Fourth Quarter 2020 Financial Results on February 18, 2021

MARLBOROUGH, Mass. and BERLIN, Germany and YOKNEAM ILIT, Israel, Feb. 15, 2021 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that the Company will release its fourth quarter 2020 financial results on Thursday,...

RWLK - ReWalk Robotics gains as Hyundai working on car that turns into "walking machine"

ReWalk Robotics (RWLK) soared 20% as a CNBC report hit that said Hyundai Motor Group (HYMLF) is working on a concept car that can be turned into a "four-legged walking machine."The vehicle, known as TIGER, is being designed to operate without a crew and in "extreme, remote loca...

Previous 10 Next 10